138 related articles for article (PubMed ID: 33923088)
1. Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality.
Baudhuin H; Puttemans J; Hanssens H; Vanwolleghem P; Hernot S; Raes G; Xavier C; Lahoutte T; Debie P
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33923088
[TBL] [Abstract][Full Text] [Related]
2. Clinical Translation of [
Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
[TBL] [Abstract][Full Text] [Related]
3. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for
Baudhuin H; Van Bockstal PJ; De Beer T; Vaneycken I; Bridoux J; Raes G; Caveliers V; Keyaerts M; Devoogdt N; Lahoutte T; Xavier C
Eur J Pharm Biopharm; 2021 Sep; 166():194-204. PubMed ID: 34186190
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
5.
Baudhuin H; Cousaert J; Vanwolleghem P; Raes G; Caveliers V; Keyaerts M; Lahoutte T; Xavier C
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34068666
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
7. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
8. An Efficient Method for Labeling Single Domain Antibody Fragments with
Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
[TBL] [Abstract][Full Text] [Related]
9. Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.
Wüstemann T; Bauder-Wüst U; Schäfer M; Eder M; Benesova M; Leotta K; Kratochwil C; Haberkorn U; Kopka K; Mier W
Theranostics; 2016; 6(8):1085-95. PubMed ID: 27279903
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of a (67)Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag).
Morais M; Cantante C; Gano L; Santos I; Lourenço S; Santos C; Fontes C; Aires da Silva F; Gonçalves J; Correia JD
Nucl Med Biol; 2014 May; 41 Suppl():e44-8. PubMed ID: 24530366
[TBL] [Abstract][Full Text] [Related]
11. Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma.
Krasniqi A; D'Huyvetter M; Xavier C; Van der Jeught K; Muyldermans S; Van Der Heyden J; Lahoutte T; Tavernier J; Devoogdt N
Mol Cancer Ther; 2017 Dec; 16(12):2828-2839. PubMed ID: 29054987
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
13. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation.
Zhou Z; Chitneni SK; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioorg Med Chem; 2018 May; 26(8):1939-1949. PubMed ID: 29534937
[TBL] [Abstract][Full Text] [Related]
15. Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[
Zhou Z; McDougald D; Devoogdt N; Zalutsky MR; Vaidyanathan G
Mol Pharm; 2019 Jan; 16(1):214-226. PubMed ID: 30427188
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
Qi S; Hoppmann S; Xu Y; Cheng Z
Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
[TBL] [Abstract][Full Text] [Related]
17. Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies.
Nguyen TD; Bordeau BM; Zhang Y; Mattle AG; Balthasar JP
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613917
[TBL] [Abstract][Full Text] [Related]
18. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.
D'Huyvetter M; Aerts A; Xavier C; Vaneycken I; Devoogdt N; Gijs M; Impens N; Baatout S; Ponsard B; Muyldermans S; Caveliers V; Lahoutte T
Contrast Media Mol Imaging; 2012; 7(2):254-64. PubMed ID: 22434639
[TBL] [Abstract][Full Text] [Related]
19. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.
Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA
Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Targeted α- and β
Puttemans J; Dekempeneer Y; Eersels JL; Hanssens H; Debie P; Keyaerts M; Windhorst AD; van der Aa F; Lecocq Q; Breckpot K; Morgenstern A; Bruchertseifer F; Lahoutte T; Devoogdt N; D'Huyvetter M
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32326199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
